These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27522992)

  • 1. Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.
    Nanno S; Koh H; Katayama T; Hashiba M; Sato A; Makuuchi Y; Nagasaki J; Kuno M; Yoshimura T; Okamura H; Nishimoto M; Hirose A; Nakamae M; Nakane T; Hino M; Nakamae H
    Intern Med; 2016; 55(16):2173-84. PubMed ID: 27522992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies.
    Koh H; Nanno S; Katayama T; Hirose A; Nakamae M; Hino M; Nakamae H
    Leuk Lymphoma; 2017 Oct; 58(10):2489-2492. PubMed ID: 28278703
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
    Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
    Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
    Pugni L; Pietrasanta C; Milani S; Vener C; Ronchi A; Falbo M; Arghittu M; Mosca F
    PLoS One; 2015; 10(12):e0146020. PubMed ID: 26720209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis.
    Sonoda M; Ishimura M; Eguchi K; Shiraishi A; Kanno S; Kaku N; Inoue H; Motomura Y; Ochiai M; Sakai Y; Nakayama M; Ohara O; Ohga S
    Int J Hematol; 2020 Jan; 111(1):131-136. PubMed ID: 31549293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
    Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
    Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome.
    Tabata C; Tabata R
    Ann Hematol; 2012 Jan; 91(1):63-71. PubMed ID: 21523380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis by human monocytes is required for the secretion of presepsin.
    Arai Y; Mizugishi K; Nonomura K; Naitoh K; Takaori-Kondo A; Yamashita K
    J Infect Chemother; 2015 Aug; 21(8):564-9. PubMed ID: 26026662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of presepsin for outcomes and complications in enterocutaneous fistula complicated by abdominal sepsis.
    Song X; Song Y; Yuan Y; Zhang P; Zhang X
    Int J Surg; 2016 Sep; 33 Pt A():96-101. PubMed ID: 27494999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
    Kweon OJ; Choi JH; Park SK; Park AJ
    J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
    Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of tumor necrosis factor α and interferon γ in patients with hemophagocytic syndrome and its clinical significance].
    Wu DX; Wang Z; Lin RR; Wang XL; Wang YN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1505-8. PubMed ID: 22169313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
    Baraka A; Zakaria M
    Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
    Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
    BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
    Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
    Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
    Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
    J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
    Takahashi W; Nakada TA; Yazaki M; Oda S
    Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
    Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercytokinemia in hemophagocytic syndrome.
    Fujiwara F; Hibi S; Imashuku S
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):92-8. PubMed ID: 8447564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.